| Date Filed | Type | Description |
| 04/27/2021 |
GN
| New Preclinical Data from Dyne Therapeutics' Myotonic Dystrophy Type 1 Program to be Featured in Presentations During Upcoming American Society of Gene & Cell Therapy Annual Meeting |
| 03/04/2021 |
GN
| Dyne Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Highlights |
| 01/20/2021 |
GN
| Dyne Therapeutics Announces Pricing of $168 Million Public Offering |
| 01/10/2021 |
GN
| Dyne Therapeutics Myotonic Dystrophy Type 1 Program Achieves Robust RNA Knock Down of Toxic Human Nuclear DMPK in Preclinical Study |
| 11/09/2020 |
GN
| Dyne Therapeutics to Present at Upcoming Investor Conferences |
| 11/05/2020 |
GN
| Dyne Therapeutics Reports Third Quarter 2020 Financial Results and Recent Highlights |
| 09/21/2020 |
GN
| Dyne Therapeutics Announces Closing of Initial Public Offering |
| 09/16/2020 |
GN
| Dyne Therapeutics Announces Pricing of Initial Public Offering |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 05/08/2018 |
SC 13G/A
| MASSACHUSETTS FINANCIAL SERVICES CO reports a 0% stake in DYNEGY INC. |
| 04/27/2018 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 04/27/2018 |
10-K/A
| Annual Report for the period ended December 31, 2017 [amend] |
| 04/09/2018 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta... |
| 04/09/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/09/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/09/2018 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
| 04/09/2018 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 04/09/2018 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 04/09/2018 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 04/04/2018 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 03/06/2018 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/02/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/27/2018 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 02/26/2018 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 02/26/2018 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 02/22/2018 |
10-K
| Annual Report for the period ended December 31, 2017 |
| 02/21/2018 |
8-K
| Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits |
| 02/21/2018 |
BW
| Dynegy Announces 2017 Financial Results |
| 02/21/2018 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 02/14/2018 |
SC 13G/A
| Point72 Asset Management, L.P. reports a |
| 02/14/2018 |
SC 13G
| DEUTSCHE BANK AG\ reports a 9.3% stake in DYNEGY INC |
| 02/13/2018 |
SC 13G/A
| Avenue Capital Management II, L.P. reports a 1.2% stake in Dynegy Inc. |
| 02/13/2018 |
SC 13G/A
| CARLSON CAPITAL L P reports a 0% stake in Dynegy Inc. |
|